trending Market Intelligence /marketintelligence/en/news-insights/trending/x-fXjTjpddjZKVoSLVVXVA2 content esgSubNav
In This List

Allergan COO to leave company

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints

Blog

Shore Capital is Now Available in S&P Global’s Aftermarket Research Collection


Allergan COO to leave company

Allergan plc executive vice president and COO Rob Stewart is leaving the company to become the president of Amneal Pharmaceuticals LLC on Jan. 25, 2018.

Wayne Swanton has been appointed Allergan's executive vice president of global operations following Stewart's notification that he is leaving.

Stewart will become the president, CEO and board member of Amneal Pharmaceuticals once it combines with Impax Laboratories Inc.

The combined company will be known as Amneal Pharmaceuticals, and will see Impax President and CEO Paul Bisaro become its executive chairman.

Meanwhile, Amneal's co-CEOs and co-founders, Chirag Patel and Chintu Patel, will serve as co-chairmen of the combined company's board.